Cheng Guo

8PUBLICATIONS
7CO-AUTHORS
Biomolecular modelling and designMolecular targetsCancer cell biologyCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 24, 2026
Identification of a candidate PRODH allosteric inhibitor MBTP-15324: modulation of proline metabolite profiles and ECM-associated gene-expression changes in lung cancer cells.

|Jul 25, 2026
Targeting the CD47-SIRPĪ± phagocytic checkpoint in cancer: Biology, translational opportunities, and next-generation therapeutic strategies.

|Mar 17, 2026
6-Shogaol Attenuates Doxorubicin-Induced Cardiac and Skeletal Muscle Atrophy by Inhibiting E3 Ubiquitin Ligases and Necroptosis.

Xipeng Sun, Yaxian Wang, Quanjun Yang

|Sep 08, 2025
Arginine Metabolism in Cancer Biology and Immunotherapy.

DingYuan Bai, YuXuan Zhou, LingJie Jing

|Sep 23, 2023
Oncometabolite D-2-hydroxyglutarate-dependent metabolic reprogramming induces skeletal muscle atrophy during cancer cachexia.

Xinting Zhu, Juan Hao, Hong Zhang

|Apr 19, 2023
Cucurbitacin IIb attenuates cancer cachexia induced skeletal muscle atrophy by regulating the IL-6/STAT3/FoxO signaling pathway.

Yaxian Wang, Xipeng Sun, Quanjun Yang

Pageof 2

Frequent Collaborators

5 joint publications

Quanjun Yang

2 joint publications

Xipeng Sun

1 joint publications

Ting Yuan

1 joint publications

DingYuan Bai